Oftacilox (Ciprofloxacin Hydrochloride)

Ciprofloxacin inhibits bacterial DNA gyrase and topoisomerase IV, enzymes required for DNA replication and transcription. This inhibition stops bacterial cell division, leading to rapid bactericidal activity against a broad range of ocular pathogens.

The specific dosing regimen for Oftacilox is determined by the prescribing eye care professional based on the infection type, severity, and patient factors. The prescriber will provide exact instructions on frequency and duration of use.

Ciprofloxacin is classified as a pregnancy‑category C drug. It should be used during pregnancy or lactation only if the potential benefit justifies any potential risk to the fetus or infant. The prescriber will assess the risk‑benefit profile for each individual.

To order Oftacilox, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India supplies hospitals, pharmacies, and procurement teams worldwide, and will request trade or institutional credentials before providing pricing, availability, shipping details, and any necessary import documentation.

Oftacilox (ciprofloxacin) offers broad‑spectrum coverage against both Gram‑negative and Gram‑positive ocular bacteria, often providing a wider antimicrobial spectrum than older agents such as chloramphenicol. Its fluoroquinolone class also tends to have a lower resistance rate in many regions, making it a preferred choice for many clinicians.

Oftacilox should be stored at room temperature below 25°C. Keep the bottle in its original packaging, protect it from direct light and moisture, and discard any solution that appears discolored or cloudy.

Oftacilox is applied topically to the eye as directed by the prescriber. Typically, a few drops are instilled into the affected eye(s) at the prescribed frequency, ensuring the eyelids are gently closed after administration to allow proper absorption.

Serious risks, though rare, include severe allergic reactions, corneal ulceration or perforation, and systemic fluoroquinolone effects such as tendonitis or central nervous system disturbances if significant systemic absorption occurs. Patients should seek immediate medical attention if they experience worsening eye pain, vision changes, or signs of an allergic reaction.

Individuals with a known hypersensitivity to ciprofloxacin, other fluoroquinolones, or any component of the formulation should avoid using Oftacilox. Caution is also advised for patients with a history of tendon disorders related to fluoroquinolones, and it should be used only under medical supervision in pregnant or lactating women.